Practical Considerations for the Nonvitamin K Antagonist Oral Anticoagulants | Citedby Results | Cardiology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Practical Considerations for the Nonvitamin K Antagonist Oral Anticoagulants

Cardiology (2017) 136 (2): 115–124.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Comparative outcomes of manual compression, double-ProGlide and the LaPFOE technique following cryoballoon atrial fibrillation ablation with uninterrupted oral anticoagulants

Jiayin Sun
Ji Wu
Hailiang Yu
Debao Zhang
Hongya Han
Zhiming Zhou
Dean Jia
Dongmei Shi
Yujie Zhou
Shiwei Yang

BMC Cardiovascular Disorders (2025) 25 (1)

Association Between Concurrent Use of Amiodarone and DOACs and Risk of Bleeding in Patients With Atrial Fibrillation

Mohammed Shurrab
Cynthia A. Jackevicius
Peter C. Austin
Karen Tu
Feng Qiu
Sheldon M. Singh
Eugene Crystal
Joseph Caswell
Faith Michael
Jason G. Andrade
Dennis T. Ko

The American Journal of Cardiology (2023) 186: 58.

Association between concurrent use of diltiazem and DOACs and risk of bleeding in atrial fibrillation patients

Mohammed Shurrab
Cynthia A. Jackevicius
Peter C. Austin
Karen Tu
Feng Qiu
Joseph Caswell
Faith Michael
Jason G. Andrade
Dennis T. Ko

Journal of Interventional Cardiac Electrophysiology (2022) 10.1007/s10840-022-01355-1

Akılcı ilaç kullanımı: Yeni nesil oral antikoagülanlar

Nur AKAD SOYER

Ege Tıp Dergisi 32.

Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide

Chia Siang Kow
Wendy Sunter
Amie Bain
Syed Tabish Razi Zaidi
Syed Shahzad Hasan

American Journal of Cardiovascular Drugs (2020) 20 (4): 301.

Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease

Junaid A. B. Zaman
Anil K. Bhandari

Journal of Cardiovascular Pharmacology and Therapeutics (2019) 24 (6): 499.

Saudi Heart Association (SHA) guidelines for the management of heart failure

Waleed AlHabeeb
Fakhr Al-Ayoubi
Kamal AlGhalayini
Fahad Al Ghofaili
Yahya Al Hebaishi
Abdulrazaq Al-Jazairi
Mouaz H. Al-Mallah
Ali AlMasood
Maryam Al Qaseer
Shukri Al-Saif
Ammar Chaudhary
Abdelfatah Elasfar
Adel Tash
Mohamed Arafa
Walid Hassan

Journal of the Saudi Heart Association (2019) 31 (4): 204.

2‐Aminobenzamide‐Based Factor Xa Inhibitors with Novel Mono‐ and Bi‐Aryls as S4 Binding Elements

Nirav R. Patel
Dushyant V. Patel
Ashish M. Kanhed
Sagar P. Patel
Kirti V. Patel
Daniel K. Afosah
Umesh R. Desai
Rajshekhar Karpoormath
Mange Ram Yadav

ChemistrySelect (2019) 4 (3): 802.

Design, synthesis and biological evaluation of anthranilamide derivatives as potential factor Xa (fXa) inhibitors

Junhao Xing
Lingyun Yang
Jinpei Zhou
Huibin Zhang

Bioorganic & Medicinal Chemistry (2018) 26 (23-24): 5987.

Creatinine Versus Cystatin C: Differing Estimates of Renal Function in Hospitalized Veterans Receiving Anticoagulants

Christina Hao Wang
Anna D. Rubinsky
Tracy Minichiello
Michael G. Shlipak
Erika Leemann Price

Journal of General Internal Medicine (2018) 33 (8): 1299.

Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal

Sujan T. Reddy
TC Cossey
Sean I. Savitz
James C. Grotta

Current Neurology and Neuroscience Reports (2017) 17 (9)

Comparison of the Incidences of Complications After Second-Generation Cryoballoon Ablation of Atrial Fibrillation Using Vitamin K Antagonists Versus Novel Oral Anticoagulants

Giacomo Mugnai
Carlo de Asmundis
Saverio Iacopino
Erwin Stroker
Massimo Longobardi
Valentina De Regibus
Hugo Enrique Coutino-Moreno
Ken Takarada
Rajin Choudhury
Juan Pablo Abugattas de Torres
Cesare Storti
Pedro Brugada
Gian-Battista Chierchia

The American Journal of Cardiology (2017) 120 (2): 223.